Healthcare/Biotech
Opioid Tapentadol may be put under Narcotics Act to curb its access
The government is planning to regulate Tapentadol under the Narcotic Drugs and Psychotropic Substances Act. This follows concerns about its misuse and exports to West Africa. The move aims to control its availability. The Narcotics Control Bureau and police will oversee its movement. Tapentadol is a pain management drug with limited alternative treatment options.
- Ranitidine ban deferred despite cancer concerns
- BDR Pharmaceuticals plans $100 mn expansion in the US with manufacturing buyouts
- Aster DM Healthcare completes acquisition of 5% stake in Quality Care India through share swap
- Zydus Lifesciences gets USFDA nod for generic cholesterol lowering drug
- Max Healthcare lines up Rs 6,000 crore for expansion
- Max Healthcare Institute to invest Rs 6,000 cr to add 3,700 beds by 2028
- Medanta to invest Rs 500 cr to set up 400-bed hospital in Guwahati
- Dr Reddy's to introduce Sanofi's novel drug in India
- Japan's Takeda to launch dengue vaccine in India with Biological E next year
- Roche made over 100 times the cost of a medicine that it sold in India, calculations show; company defends itself
- Get evergreening patent requests very often, these benefit select few cos: Piyush Goyal
- Zydus gets 6 observations from USFDA for API unit
Roche made over 100 times the cost of a medicine that it sold in India, calculations show; company defends itself
Get evergreening patent requests very often, these benefit select few cos: Piyush Goyal
Zydus gets 6 observations from USFDA for API unit
SS Innovations International listed on US exchange Nasdaq
Reckitt Benckiser's rare reflection: India a big growth driver
To speed up delivery, govt exempts orphan drugs from testing at ports
Biotech
Biocon Biologics secures market entry for Yesafili in US- Bharat Biotech invests Rs 600 cr to expand into cell, gene therapies
- Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028
- India's Syngene International acquires first US biologics facility for $36.5 million
- States to set up centres for effective implementation of BioE3 policy: Jitendra Singh
Healthcare
Aster DM Healthcare completes acquisition of 5% stake in Quality Care India through share swap- Max Healthcare lines up Rs 6,000 crore for expansion
- Max Healthcare Institute to invest Rs 6,000 cr to add 3,700 beds by 2028
- Medanta to invest Rs 500 cr to set up 400-bed hospital in Guwahati
- Get evergreening patent requests very often, these benefit select few cos: Piyush Goyal
Pharmaceuticals
Must Watch
BACK TO TOP